Article
Cytoimmunologic monitoring and heart transplantation.
The Journal of heart transplantation - 1 Jan 2000
Hanson C A, Bolling S F, Stoolman L M, Schlegelmilch J A, Abrams G D, Miska P T, Deeb G M
Abstract excerpt
Cytoimmunologic monitoring (CIM) combines morphological quantitation of activated lymphocytes and immunoblasts with immunophenotyping of peripheral blood in an effort to identify patients at risk for heart transplant rejection. In this study, CIM and endomyocardial biopsy (EMB) results were correlated in 55 paired blood and tissue specimens obtained from 18 heart transplant patients after operation. We found that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
